218 results on '"Tolley, Keith"'
Search Results
2. Pre-analysis stage
3. The cost-effectiveness of counselling Reviewing the evidence
4. Evaluating the Cost-Effectiveness of Counselling in Health Care
5. The main types of economic evaluation
6. Counselling case studies
7. Analysing cost-effectiveness data
8. The economic evaluation of counselling
9. Data collection I
10. Economics, ethics and counselling
11. The components of an economic evaluation
12. Investigation of Health-Related Quality of Life Outcomes in Cancer Patients: Findings from an Observational Study Using the EQ-5D in Italy
13. A cost-utility analysis of ingenol mebutate gel for the treatment of actinic keratosis: a Scottish perspective
14. Reimbursement of Targeted Cancer Therapies Within 3 Different European Health Care Systems
15. Comparative Effectiveness of Adding Alogliptin to Metformin Plus Sulfonylurea with Other DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
16. Exploring the impact of excessive daytime sleepiness caused by obstructive sleep apnea on patient and partner quality of life: a time trade-off utility study in the UK general public
17. Model parameters influencing the cost-effectiveness of sacubitril/valsartan in heart failure: evidence from a systematic literature review
18. Utility elicitation study in the UK general public for late-stage chronic lymphocytic leukaemia
19. Cost effectiveness of lanthanum carbonate in chronic kidney disease patients in Spain before and during dialysis
20. Mapping EQ-5D Utility Scores from the Incontinence Quality of Life Questionnaire among Patients with Neurogenic and Idiopathic Overactive Bladder
21. Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Dialysis Patients: A Canadian Payer Perspective
22. Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Chronic Kidney Disease Before and During Dialysis
23. An Economic Evaluation of Short-Acting Opioids for Treatment of Breakthrough Pain in Patients with Cancer
24. Lifetime Cost-Utility Analyses of Deferasirox in Beta-Thalassaemia Patients with Chronic Iron Overload: A UK Perspective
25. GP fundholding and the costs of prescribing: further results
26. Reducing the burden of coronary heart disease: health promotion, its effectiveness and cost
27. RESPONSE: Health promotion and health economics
28. Explaining Variations In General Practice Prescribing Costs Per ASTRO-PU (Age, Sex, And Temporary Resident Originated Prescribing Unit)
29. Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disorders
30. Cost-effectiveness of a tetravalent human papillomavirus vaccine in Germany
31. Cost Effectiveness of Itraconazole in the Prophylaxis of Invasive Fungal Infections
32. Patient-Reported Visual Function Outcomes Improve After Ranibizumab Treatment in Patients With Vision Impairment Due to Diabetic Macular Edema: Randomized Clinical Trial
33. A multicentre study of patient survival, disability, quality of life and cost of care: Among patients with AIDS in Northern Italy
34. Cost-Utility Analysis of Primary Prophylaxis versus Treatment On-Demand for Individuals with Severe Haemophilia
35. The Cost of HIV Treatment and Care: A Global Review
36. Hospital care for p ersons with AIDS in European‐Union countries; a cross‐country comparison
37. The Use and Cost of HIV Service Provision in England in 1996
38. General Practitioner Fundholding and Prescribing Expenditure Control: Evidence from a Rural English Health Authority
39. Interferon-β in Multiple Sclerosis: Can We Control its Costs?
40. 8th European Conference on Rare Diseases & Orphan Products (ECRD 2016)
41. Discounting of Health Benefits in the Pharmacoeconomic Analysis of Drug Therapies: An Issue for Debate?
42. Hospital care for persons with AIDS in European‐Union countries; a cross‐country comparison
43. Cost-effectiveness and cost-benefit in the prevention of mother-to-child transmission of HIV in developing countries
44. Efficiency and rationality in the planning of health care for people with AIDS: an application of the balance of care approach
45. Prescribing costs in UK general practice: the impact of hard budget constraints
46. Hospital costs of treating haetnophilic patients infected with HIV
47. Economic impact of the AIDS epidemic in the European Community: towards multinational scenarios on hospital care and costs
48. An economic evaluation of home-care assistance for AIDS patients: a pilot study in a town in northern Italy
49. An assessment of innovative pricing schemes for the communication of value: is price discrimination and two-part pricing a way forward?
50. GP fundholding and the costs of prescribing
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.